Cardiovascular disease is the leading cause of death globally, primarily due to ischemic heart disease and subsequent acute coronary syndrome (ACS). ACS not only impacts physical function, but also psychological wellbeing. Patients who experience acute cardiovascular events are at elevated risk for experiencing symptoms of anxiety and depression. Further, increased levels of depression and anxiety following ACS is associated with amplified morbidity and mortality. Secondary prevention focusing on psychological well-being must be prioritized in this population to improve quality of life and cardiovascular health. The purpose of the present review is to summarize the literature on secondary prevention following ACS via interventions aimed at reducing depression and anxiety. Due to the heterogeneity of programs identified, a large, randomized control trial comparing their efficacy is vital to improving outcomes in this population.
Crown Copyright © 2022. Published by Elsevier Inc. All rights reserved.